PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7615481

Lithium tremor.

A J Gelenberg·J W Jefferson
View original source ↗Export metadata ↓

Abstract

BACKGROUND: Tremor is a common problem for patients taking lithium, but little is known about its true prevalence, its effect on compliance, and effective treatments. METHOD: The data base of the Lithium Information Center in Madison, Wis., was searched for articles relating to lithium tremor. RESULTS: Studies show a wide range of incidence of lithium tremor--4% to 65%--due to differences in defining and reporting this side effect. While lithium tremor often decreases with time on lithium, other treatment options include changing the dose or preparation of lithium, decreasing or eliminating other drugs, and treating with beta-blocking drugs, primidone, fatty acids, or potassium. Severe tremor may be a sign of lithium toxicity. CONCLUSION: Patients should be evaluated for lithium tremor on a regular basis. Diagnostic criteria should be standardized by a double-blind, random assignment, multicenter study that could also investigate proposed treatments.

Explore related subjects

Adrenergic beta-AntagonistsClinical Trials as TopicDrug Information ServicesFemaleHumansIncidenceLithiumMalePatient CompliancePrevalenceTremorJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A J Gelenberg, J W Jefferson. 1995. Lithium tremor.. https://pubmed.ncbi.nlm.nih.gov/7615481/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.

BACKGROUND AND METHODS: We compared propranolol therapy and endoscopic ligation for the primary prevention of bleeding from esophageal varices. This prospective, controlled trial included consecutive eligible patients who had large varices (>5 mm in diameter) that were at high risk for bleeding. The patients were assigned to either propranolol therapy, at a dose sufficient to decrease the base-line heart rate by 25 percent, or variceal ligation, to be performed weekly until the varices were obliterated or so reduced in size that it was not possible to continue treatment. RESULTS: Of the 89 patients, 82 of whom had cirrhosis of the liver, 44 received propranolol and 45 underwent variceal ligation. The mean (+/-SD) duration of follow-up in each group was 14+/-9 and 13+/-10 months, respectively. The mean time required to achieve an adequate reduction in the heart rate was 2.5+/-1.7 days; the mean number of sessions needed to complete variceal ligation was 3.2+/-1.1. After 18 months, the actuarial probability of bleeding was 43 percent in the propranolol group and 15 percent in the ligation group (P=0.04). Twelve patients in the propranolol group and four in the ligation group had bleeding. Three of the four in the ligation group had bleeding before their varices had been obliterated. Nine patients in the ligation group had recurrent varices, a mean of 3.7 months after the initial treatment. Five patients in each group died; bleeding from the varices was the cause of death of four patients in the propranolol group and of three in the ligation group. There were no serious complications of variceal ligation; in the propranolol group, treatment was stopped in two patients because of side effects. CONCLUSIONS: In patients with high-risk esophageal varices, endoscopic ligation of the varices is safe and more effective than propranolol for the primary prevention of variceal bleeding.

Adrenergic beta-Antagonists↗
PubMed1999

Structural parameters involved in the permeation of propranolol HCl by iontophoresis and enhancers.

The purpose of this work was to study the effect of iontophoretic transport of Propranolol hydrochloride on the lipidic organization of the stratum corneum pretreated under passive or iontophoretic conditions by two model penetration enhancers, sodium lauryl sulfate and hexadecyl trimethylammonium bromide. Characterization of human stratum corneum was performed by X-ray diffraction, attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy and differential scanning calorimetry (DSC). The structural properties were compared with the iontophoretic permeability of propranolol hydrochloride on human stratum corneum. The iontophoretic fluxes of propranolol hydrochloride were effectively increased by two-fold in stratum corneum pretreated with sodium lauryl sulfate. In contrast, they were halved in stratum corneum pretreated with hexadecyl trimethylammonium bromide. These results could be related to changes in the electrical and structural properties of the stratum corneum after incorporation of these enhancers.

Adrenergic beta-Antagonists↗